Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AC Immune SA

    NASDAQ: ACIU · Real-Time Price · USD
    1.95
    -0.12 (-5.80%)
    At close: Jun 13, 2025, 3:59 PM
    1.97
    1.03%
    After-hours: Jun 13, 2025, 06:56 PM EDT

    AC Immune SA Statistics

    Share Statistics

    AC Immune SA has 98.94M shares outstanding. The number of shares has increased by -0.26% in one year.

    Shares Outstanding

    n/a
    		 98.94M

    Shares Change (YoY)

    n/a
    		 -0.26%

    Shares Change (QoQ)

    n/a
    		 -0.74%

    Owned by Institutions (%)

    n/a
    		 24.87%

    Shares Floating

    n/a
    		 61.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,900

    FTD / Avg. Volume

    n/a
    		 1.24%

    Short Selling Information

    The latest short interest is 1.39M, so 1.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.39M

    Short % of Shares Out

    n/a
    		 1.38%

    Short % of Float

    n/a
    		 2.92%

    Short Ratio (days to cover)

    n/a
    		 13.83

    Valuation Ratios

    The PE ratio is -4.8 and the forward PE ratio is -3.04. AC Immune SA's PEG ratio is 0.24.

    PE Ratio

    n/a
    		 -4.8

    Forward PE

    n/a
    		 -3.04

    PS Ratio

    n/a
    		 8.95

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 2.18

    P/FCF Ratio

    n/a
    		 3.74

    PEG Ratio

    n/a
    		 0.24
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for AC Immune SA.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 1.71

    Quick Ratio

    n/a
    		 1.71

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.11

    Debt / FCF

    n/a
    		 0.08

    Interest Coverage

    n/a
    		 -393.82

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $205,330.83

    Profits Per Employee

    n/a
    		 $-382,827.07

    Employee Count

    n/a
    		 133

    Asset Turnover

    n/a
    		 0.12

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 3K

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by -54.23% in the last 52 weeks. The beta is 1.58, so AC Immune SA's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.58

    52-Week Price Change

    n/a
    		 -54.23%

    50-Day Moving Average

    n/a
    		 1.69

    200-Day Moving Average

    n/a
    		 2.6

    Relative Strength Index (RSI)

    n/a
    		 57.36

    Average Volume (20 Days)

    n/a
    		 152,642

    Income Statement

    In the last 12 months, AC Immune SA had revenue of 27.31M and earned -50.92M in profits. Earnings per share was -0.51.

    Revenue

    n/a
    		 27.31M

    Gross Profit

    n/a
    		 27.31M

    Operating Income

    n/a
    		 -52.38M

    Net Income

    n/a
    		 -50.92M

    EBITDA

    n/a
    		 -48.62M

    EBIT

    n/a
    		 -50.78M

    Earnings Per Share (EPS)

    n/a
    		 -0.51
    Full Income Statement

    Balance Sheet

    The company has 36.27M in cash and 5.43M in debt, giving a net cash position of 30.85M.

    Cash & Cash Equivalents

    n/a
    		 36.27M

    Total Debt

    n/a
    		 5.43M

    Net Cash

    n/a
    		 30.85M

    Retained Earnings

    n/a
    		 -368.24M

    Total Assets

    n/a
    		 211.08M

    Working Capital

    n/a
    		 52.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 65.84M and capital expenditures -576K, giving a free cash flow of 65.27M.

    Operating Cash Flow

    n/a
    		 65.84M

    Capital Expenditures

    n/a
    		 -576K

    Free Cash Flow

    n/a
    		 65.27M

    FCF Per Share

    n/a
    		 0.65
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -191.8% and -186.44%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -191.8%

    Pretax Margin

    n/a
    		 -186.43%

    Profit Margin

    n/a
    		 -186.44%

    EBITDA Margin

    n/a
    		 -178.03%

    EBIT Margin

    n/a
    		 -191.8%

    FCF Margin

    n/a
    		 238.99%

    Dividends & Yields

    ACIU does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ACIU is $12, which is 515.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 515.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.08

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist